AstraZeneca’s acquisition of Fusion Pharmaceuticals for up to $2.4 billion signals a strategic move to bolster its cancer portfolio, particularly… Continue Reading
Articles
PocketHealth | Revolutionizing Healthcare Access and Efficiency
PocketHealth, fueled by a $33 million Series B funding, redefines healthcare accessibility and efficiency. Founded in 2016, it empowers patients… Continue Reading
Hippocratic AI | Revolutionizing Healthcare with Generative AI
Hippocratic AI secures $53 million in oversubscribed Series A funding, bringing total raised to $120 million, with a valuation of… Continue Reading
Conduce Health | Pioneering Value-Based Care Revolution
Conduce Health secures $3M funding for its innovative approach to value-based care, addressing challenges in specialty care coordination. Their marketplace… Continue Reading
Cybin | Revolutionizing Mental Health with Innovative Psychedelic Therapies
Cybin Inc. (NYSE American: CYBN) secures $150M in private funding, led by Deep Track Capital, to advance CYB003, a groundbreaking… Continue Reading
AI Revolutionizes Surgery | J&J and NVIDIA Partner
Johnson & Johnson MedTech and NVIDIA collaborate to integrate AI into surgical procedures, aiming to enhance real-time analysis and decision-making… Continue Reading
AI-Powered Healthcare | Banner Health’s Transformational Partnership
Banner Health in Phoenix deepens its collaboration with Regard, a Los Angeles-based clinical decision software firm, to integrate AI-driven solutions… Continue Reading
Revolutionizing Rheumatology | Remission & Sentara’s Dynamic Partnership
Remission Medical and Sentara Health join forces to enhance rheumatology care access. Leveraging telehealth solutions, patients can receive virtual triage… Continue Reading
Advancing Healthcare| Innovations in Screening and Monitoring
The Global Fund collaborates with VinBrain to enhance TB screening in Vietnam. VinBrain’s AI technology aims to expedite diagnosis and… Continue Reading
PureTech Celebrates Karuna Acquisition by Bristol Myers Squibb
PureTech Health plc announces the acquisition of Karuna Therapeutics, Inc. by Bristol Myers Squibb for $14 billion, emphasizing KarXT’s potential… Continue Reading